Extracellular Vesicle Therapy Reduces Neuroinflammation and Supports Healthy Brain Aging

Extracellular Vesicle Therapy Reduces Neuroinflammation and Supports Healthy Brain Aging
 

This report highlights recently published research investigating the effects of intranasal human neural stem cell-derived extracellular vesicles (EVs) in aged experimental models. The study examined whether EV therapy could influence neuroinflammatory processes associated with brain aging and age-related cognitive decline.

Particular attention was given to inflammatory signaling pathways including the NLRP3 inflammasome and cGAS-STING pathway, both of which have been implicated in age-associated neuroinflammation and microglial activation. Researchers also evaluated oxidative stress markers, mitochondrial-related pathways, and cognitive performance outcomes following treatment.

The findings provide scientific insight into how extracellular vesicle-based approaches may influence biological pathways associated with healthy brain aging and neuroinflammation.

Key Highlights
  • Intranasal EV therapy reduced inflammatory microglial activity in the aged hippocampus.
  • NLRP3 inflammasome and cGAS-STING signaling pathways were significantly suppressed.
  • Oxidative stress markers decreased while mitochondrial-supportive pathways increased.
  • Cognitive and memory performance improved following treatment.
  • Findings suggest a potential strategy for addressing age-related neuroinflammation.
Complete Research Publication

Access the full peer-reviewed publication describing the effects of human neural stem cell-derived extracellular vesicles on neuroinflammatory signaling, oxidative stress regulation, and cognitive function during aging.

View Full Publication
File format: PDF Research Publication
Scroll to Top